Menu
GeneBe

7-16795011-G-C

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 4P and 2B. PM1PM2BP4_Moderate

The NM_006408.4(AGR2):c.403C>G(p.Leu135Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

AGR2
NM_006408.4 missense

Scores

5
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.12
Variant links:
Genes affected
AGR2 (HGNC:328): (anterior gradient 2, protein disulphide isomerase family member) This gene encodes a member of the disulfide isomerase (PDI) family of endoplasmic reticulum (ER) proteins that catalyze protein folding and thiol-disulfide interchange reactions. The encoded protein has an N-terminal ER-signal sequence, a catalytically active thioredoxin domain, and a C-terminal ER-retention sequence. This protein plays a role in cell migration, cellular transformation and metastasis and is as a p53 inhibitor. As an ER-localized molecular chaperone, it plays a role in the folding, trafficking, and assembly of cysteine-rich transmembrane receptors and the cysteine-rich intestinal gylcoprotein mucin. This gene has been implicated in inflammatory bowel disease and cancer progression. [provided by RefSeq, Mar 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM1
In a chain Anterior gradient protein 2 homolog (size 154) in uniprot entity AGR2_HUMAN there are 8 pathogenic changes around while only 1 benign (89%) in NM_006408.4
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.21695513).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
AGR2NM_006408.4 linkuse as main transcriptc.403C>G p.Leu135Val missense_variant 7/8 ENST00000419304.7
AGR2XM_005249581.5 linkuse as main transcriptc.403C>G p.Leu135Val missense_variant 7/8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
AGR2ENST00000419304.7 linkuse as main transcriptc.403C>G p.Leu135Val missense_variant 7/81 NM_006408.4 P1
AGR2ENST00000401412.5 linkuse as main transcriptc.403C>G p.Leu135Val missense_variant 7/72
AGR2ENST00000450569.5 linkuse as main transcriptc.193C>G p.Leu65Val missense_variant 4/55

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
34
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 08, 2023The c.403C>G (p.L135V) alteration is located in exon 7 (coding exon 6) of the AGR2 gene. This alteration results from a C to G substitution at nucleotide position 403, causing the leucine (L) at amino acid position 135 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.47
BayesDel_addAF
Benign
-0.15
T
BayesDel_noAF
Benign
-0.45
Cadd
Benign
22
Dann
Uncertain
0.99
DEOGEN2
Benign
0.22
T;.;T
Eigen
Benign
-0.096
Eigen_PC
Benign
0.052
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Uncertain
0.95
D;D;D
M_CAP
Benign
0.017
T
MetaRNN
Benign
0.22
T;T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
2.0
M;.;.
MutationTaster
Benign
1.0
D;D;D
PrimateAI
Uncertain
0.70
T
PROVEAN
Benign
-0.32
N;N;N
REVEL
Benign
0.090
Sift
Benign
0.17
T;T;T
Sift4G
Benign
0.064
T;T;T
Polyphen
0.012
B;.;.
Vest4
0.39
MutPred
0.64
Gain of catalytic residue at L135 (P = 0.2014);.;Gain of catalytic residue at L135 (P = 0.2014);
MVP
0.37
MPC
0.21
ClinPred
0.42
T
GERP RS
3.6
Varity_R
0.26
gMVP
0.48

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr7-16834635; API